Market Value145,641,164
Total Holdings56
File Date2024-11-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
SRPT / Sarepta Therapeutics, Inc.
BGNE / BeiGene, Ltd. - Depositary Receipt (Common Stock)
BBIO / BridgeBio Pharma, Inc.
FULC / Fulcrum Therapeutics, Inc.
LXEO / Lexeo Therapeutics, Inc.
CYTK / Cytokinetics, Incorporated
BNTX / BioNTech SE - Depositary Receipt (Common Stock)
VRDN / Viridian Therapeutics, Inc.
ETNB / 89bio, Inc.
NUVL / Nuvalent, Inc.
GILD / Gilead Sciences, Inc.
US48576UAA43 / Karyopharm Therapeutics Inc
TVTX / Travere Therapeutics, Inc.
QTRX / Quanterix Corporation
AGIO / Agios Pharmaceuticals, Inc.
BIIB / Biogen Inc.
ALGN / Align Technology, Inc.
GKOS / Glaukos Corporation
SWTX / SpringWorks Therapeutics, Inc.
KURA / Kura Oncology, Inc.
STOK / Stoke Therapeutics, Inc.
STAA / STAAR Surgical Company
BCRX / BioCryst Pharmaceuticals, Inc.
BPMC / Blueprint Medicines Corporation
EWTX / Edgewise Therapeutics, Inc.
BMY / Bristol-Myers Squibb Company
LPTX / Leap Therapeutics, Inc.
SYRS / Syros Pharmaceuticals, Inc.
GH / Guardant Health, Inc.
TECX / Tectonic Therapeutic, Inc.
SRRK / Scholar Rock Holding Corporation
LLY / Eli Lilly and Company
RDY / Dr. Reddy's Laboratories Limited - Depositary Receipt (Common Stock)
IMAB / I-Mab - Depositary Receipt (Common Stock)
DXCM / DexCom, Inc.
ARVN / Arvinas, Inc.
WVE / Wave Life Sciences Ltd.
CRBP / Corbus Pharmaceuticals Holdings, Inc.
ABCL / AbCellera Biologics Inc.
SGMT / Sagimet Biosciences Inc.
ZLAB / Zai Lab Limited - Depositary Receipt (Common Stock)
ELEV / Elevation Oncology, Inc.
QTTB / Q32 Bio Inc.
AVDL / Avadel Pharmaceuticals plc
HLVX / HilleVax, Inc.
MDGL / Madrigal Pharmaceuticals, Inc.
CABA / Cabaletta Bio, Inc.
PMVP / PMV Pharmaceuticals, Inc.
ATEC / Alphatec Holdings, Inc.
MASI / Masimo Corporation
AUTL / Autolus Therapeutics plc - Depositary Receipt (Common Stock)
TARS / Tarsus Pharmaceuticals, Inc.
RZLT / Rezolute, Inc.
LEGN / Legend Biotech Corporation - Depositary Receipt (Common Stock)
RVNC / Revance Therapeutics, Inc.
IRON / Disc Medicine, Inc.
ACRV / Acrivon Therapeutics, Inc.
APRE / Aprea Therapeutics, Inc.
NTRA / Natera, Inc.
GERN / Geron Corporation
AMGN / Amgen Inc.
VYNE / VYNE Therapeutics Inc.
CNTA / Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock)
PLRX / Pliant Therapeutics, Inc.
AKRO / Akero Therapeutics, Inc.
MRSN / Mersana Therapeutics, Inc.
RLAY / Relay Therapeutics, Inc.
APLS / Apellis Pharmaceuticals, Inc.
TGTX / TG Therapeutics, Inc.
INSM / Insmed Incorporated
ISRG / Intuitive Surgical, Inc.
CI / The Cigna Group
ADAG / Adagene Inc. - Depositary Receipt (Common Stock)
PACB / Pacific Biosciences of California, Inc.
GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock)
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
MRUS / Merus N.V.
GOSS / Gossamer Bio, Inc.
BHVN / Biohaven Ltd.